At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC) therapy in ...
Throughline is a time machine. Each episode, we travel beyond the headlines to answer the question, "How did we get here?" We use sound and stories to bring history to life and put you into the middle ...
AstraZeneca and Daiichi Sankyo are preparing regulatory filings that could make their HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback